soul trial oral semaglutide cardiovascular outcomes 2024 results nejm (NEJM 2025): led to a 14% ↓ in major CV events vs placebo in T2DM with ASCVD or CKD — no ↑ in serious AEs. #Semaglutide #CardioDiabetes #updatesinmedicine soul trial oral semaglutide cardiovascular
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




01375-3/asset/bffa03de-3da9-472a-a80e-74f8a67c6fdd/main.assets/gr2.jpg)




















![Mountain (3) [Asia Pacific Land Program] Judge Gift Cards 2009](https://cdn.shopify.com/s/files/1/0320/9510/9259/files/bbe05096-6931-5986-afe7-305ee6b0f345.jpg?v=1784759147)



